Clinical Trials Directory

Trials / Conditions / Thyroid Eye Disease (TED)

Thyroid Eye Disease (TED)

13 registered clinical trials studyying Thyroid Eye Disease (TED) — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingMHB018A Treatment in Patients With Chronic Thyroid Eye Disease
NCT07257185
Minghui Pharmaceutical (Hangzhou) LtdPhase 3
Not Yet RecruitingStatin and Vitamin D Treatment in Patients With Thyroid Eye Disease
NCT07400757
Taipei Veterans General Hospital, TaiwanN/A
Not Yet RecruitingA Study of VV-14305 for the Treatment of Thyroid Eye Disease
NCT07404111
Kriya Therapeutics, Inc.Phase 1 / Phase 2
RecruitingOpen-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
NCT07262476
Minghui Pharmaceutical (Hangzhou) LtdPhase 3
Not Yet RecruitingComparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Diseas
NCT07308964
Sheba Medical CenterPhase 4
RecruitingA Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
NCT07211776
Zai Lab (Shanghai) Co., Ltd.Phase 3
Active Not RecruitingA Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
NCT06812325
Viridian Therapeutics, Inc.Phase 3
CompletedPsychological Burden of Thyroid Eye Disease
NCT07444190
Thomas Jefferson University—
RecruitingA Study of GenSci098 in Subjects With Active Thyroid Eye Disease
NCT06569758
Changchun GeneScience Pharmaceutical Co., Ltd.Phase 1
CompletedTriamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease
NCT07471997
Instituto de Oftalmología Fundación Conde de ValencianaN/A
Active Not RecruitingA Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroi
NCT06126783
Innovent Biologics (Suzhou) Co. Ltd.Phase 3
CompletedMulti-modal Medical Images for Extraocular Muscle Fibrosis Assessment
NCT07056114
Tianjin Eye Hospital—